Advertisement

Index by author

June 01, 1995; Volume 47,Issue 6

A

  1. Albrightson, C R

    1. Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;

  2. Ammon, H P

    1. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
      H Safayhi, E R Sailer and H P Ammon
      Molecular Pharmacology June 1995, 47 (6) 1212-1216;

  3. Arcamone, F

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

  4. Avenet, P

    1. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

B

  1. Benchekroun, M N

    1. Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;

  2. Biton, B

    1. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

  3. Blume, R

    1. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;

  4. Bockaert, J

    1. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells.
      L Fagni, M Olivier, M Lafon-Cazal and J Bockaert
      Molecular Pharmacology June 1995, 47 (6) 1239-1247;

  5. Bolos-Sy, A M

    1. Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

  6. Brooks, A I

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

C

  1. Carlson, N G

    1. N-methyl-D-aspartate receptors activate transcription of c-fos and NGFI-A by distinct phospholipase A2-requiring intracellular signaling pathways.
      L S Lerea, N G Carlson and J O McNamara
      Molecular Pharmacology June 1995, 47 (6) 1119-1125;

  2. Cheng, J

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

  3. Ciarrocchi, G

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

  4. Coffman, B L

    1. Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
      B L Coffman, M D Green, C D King and T R Tephly
      Molecular Pharmacology June 1995, 47 (6) 1101-1105;

  5. Covey, D F

    1. Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

D

  1. Dabholkar, M

    1. Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;

  2. Danesi, R

    1. Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
      R Danesi, W D Figg, E Reed and C E Myers
      Molecular Pharmacology June 1995, 47 (6) 1106-1111;

  3. Dean, G E

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

  4. Depoortere, H

    1. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

  5. Dytko, G

    1. Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;

E

  1. Erneux, C

    1. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;

  2. Evans, W E

    1. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
      E Y Krynetski, N F Krynetskaia, Y Yanishevski and W E Evans
      Molecular Pharmacology June 1995, 47 (6) 1141-1147;

F

  1. Fagni, L

    1. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells.
      L Fagni, M Olivier, M Lafon-Cazal and J Bockaert
      Molecular Pharmacology June 1995, 47 (6) 1239-1247;

  2. Faure, C

    1. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

  3. Ferrendelli, J A

    1. Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

  4. Figg, W D

    1. Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
      R Danesi, W D Figg, E Reed and C E Myers
      Molecular Pharmacology June 1995, 47 (6) 1106-1111;

  5. Focher, F

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

  6. Freeman, L C

    1. Cholinergic inhibition of slow delayed-rectifier K+ current in guinea pig sino-atrial node is not mediated by muscarinic receptors.
      L C Freeman and R S Kass
      Molecular Pharmacology June 1995, 47 (6) 1248-1254;

G

  1. Garbesi, A

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

  2. Ghadge, G D

    1. Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;

  3. Gigg, R

    1. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;

  4. Graham, D

    1. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

  5. Grandy, D K

    1. Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
      S A Hjorth, K Thirstrup, D K Grandy and T W Schwartz
      Molecular Pharmacology June 1995, 47 (6) 1089-1094;

  6. Granger, P

    1. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

  7. Green, M D

    1. Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
      B L Coffman, M D Green, C D King and T R Tephly
      Molecular Pharmacology June 1995, 47 (6) 1101-1105;

  8. Guggino, W B

    1. Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.
      X J Li, R H Xu, W B Guggino and S H Snyder
      Molecular Pharmacology June 1995, 47 (6) 1133-1140;

  9. Gustafsson, J A

    1. Cytochromes P450 of the 2D subfamily in rat brain.
      A Wyss, J A Gustafsson and M Warner
      Molecular Pharmacology June 1995, 47 (6) 1148-1155;

H

  1. Hamacher, L

    1. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;

  2. Hansen, K R

    1. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;

  3. Hersh, L B

    1. Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;

  4. Hjorth, S A

    1. Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
      S A Hjorth, K Thirstrup, D K Grandy and T W Schwartz
      Molecular Pharmacology June 1995, 47 (6) 1089-1094;

  5. Holland, K D

    1. Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

I

  1. Iafrate, E

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

J

  1. Jacobson, E

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

  2. Jin, S L

    1. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;

  3. Jordan, J

    1. Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;

K

  1. Kass, R S

    1. Cholinergic inhibition of slow delayed-rectifier K+ current in guinea pig sino-atrial node is not mediated by muscarinic receptors.
      L C Freeman and R S Kass
      Molecular Pharmacology June 1995, 47 (6) 1248-1254;

  2. King, C D

    1. Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
      B L Coffman, M D Green, C D King and T R Tephly
      Molecular Pharmacology June 1995, 47 (6) 1101-1105;

  3. Knepel, W

    1. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;

  4. Knudsen, T B

    1. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;

  5. Krynetskaia, N F

    1. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
      E Y Krynetski, N F Krynetskaia, Y Yanishevski and W E Evans
      Molecular Pharmacology June 1995, 47 (6) 1141-1147;

  6. Krynetski, E Y

    1. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
      E Y Krynetski, N F Krynetskaia, Y Yanishevski and W E Evans
      Molecular Pharmacology June 1995, 47 (6) 1141-1147;

L

  1. Lafon-Cazal, M

    1. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells.
      L Fagni, M Olivier, M Lafon-Cazal and J Bockaert
      Molecular Pharmacology June 1995, 47 (6) 1239-1247;

  2. Langer, S Z

    1. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

  3. Laurent, A B

    1. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;

  4. Lenhard, J M

    1. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;

  5. Lerea, L S

    1. N-methyl-D-aspartate receptors activate transcription of c-fos and NGFI-A by distinct phospholipase A2-requiring intracellular signaling pathways.
      L S Lerea, N G Carlson and J O McNamara
      Molecular Pharmacology June 1995, 47 (6) 1119-1125;

  6. Li, X J

    1. Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.
      X J Li, R H Xu, W B Guggino and S H Snyder
      Molecular Pharmacology June 1995, 47 (6) 1133-1140;

M

  1. Madara, J L

    1. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;

  2. Maga, G

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

  3. Makhlouf, G M

    1. Adenosine A1 receptor-mediated activation of phospholipase C-beta 3 in intestinal muscle: dual requirement for alpha and beta gamma subunits of Gi3.
      K S Murthy and G M Makhlouf
      Molecular Pharmacology June 1995, 47 (6) 1172-1179;

  4. Manzini, S

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

  5. Mathews, G C

    1. Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

  6. McCay, P B

    1. Metabolism of ethanol to 1-hydroxyethyl radicals in vivo: detection with intravenous administration of alpha-(4-pyridyl-1-oxide)-N-t-butylnitrone.
      D R Moore, L A Reinke and P B McCay
      Molecular Pharmacology June 1995, 47 (6) 1224-1230;

  7. McConnell, R T

    1. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;

  8. McNamara, J O

    1. N-methyl-D-aspartate receptors activate transcription of c-fos and NGFI-A by distinct phospholipase A2-requiring intracellular signaling pathways.
      L S Lerea, N G Carlson and J O McNamara
      Molecular Pharmacology June 1995, 47 (6) 1119-1125;

  9. Miller, R J

    1. Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;

  10. Moore, D R

    1. Metabolism of ethanol to 1-hydroxyethyl radicals in vivo: detection with intravenous administration of alpha-(4-pyridyl-1-oxide)-N-t-butylnitrone.
      D R Moore, L A Reinke and P B McCay
      Molecular Pharmacology June 1995, 47 (6) 1224-1230;

  11. Murthy, K S

    1. Adenosine A1 receptor-mediated activation of phospholipase C-beta 3 in intestinal muscle: dual requirement for alpha and beta gamma subunits of Gi3.
      K S Murthy and G M Makhlouf
      Molecular Pharmacology June 1995, 47 (6) 1172-1179;

  12. Myers, C E

    1. Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
      R Danesi, W D Figg, E Reed and C E Myers
      Molecular Pharmacology June 1995, 47 (6) 1106-1111;

N

  1. Nahorski, S R

    1. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;

  2. Nambi, P

    1. Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;

O

  1. Olivier, M

    1. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells.
      L Fagni, M Olivier, M Lafon-Cazal and J Bockaert
      Molecular Pharmacology June 1995, 47 (6) 1239-1247;

P

  1. Pan, Y X

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

  2. Parker, R

    1. Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;

  3. Pasternak, G W

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

  4. Prehn, J H

    1. Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;

  5. Primrose, W U

    1. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;

  6. Puffinbarger, N K

    1. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;

  7. Pullen, M

    1. Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;

R

  1. Reddy, P A

    1. Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

  2. Reed, E

    1. Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
      R Danesi, W D Figg, E Reed and C E Myers
      Molecular Pharmacology June 1995, 47 (6) 1106-1111;
    2. Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;

  3. Reinke, L A

    1. Metabolism of ethanol to 1-hydroxyethyl radicals in vivo: detection with intravenous administration of alpha-(4-pyridyl-1-oxide)-N-t-butylnitrone.
      D R Moore, L A Reinke and P B McCay
      Molecular Pharmacology June 1995, 47 (6) 1224-1230;

  4. Resta, R

    1. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;

  5. Roos, R P

    1. Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;

  6. Rossi, G

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

  7. Rössig, L

    1. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;

  8. Rothman, S M

    1. Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

  9. Ryan-Moro, J

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

S

  1. Safayhi, H

    1. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
      H Safayhi, E R Sailer and H P Ammon
      Molecular Pharmacology June 1995, 47 (6) 1212-1216;

  2. Sailer, E R

    1. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
      H Safayhi, E R Sailer and H P Ammon
      Molecular Pharmacology June 1995, 47 (6) 1212-1216;

  3. Scatton, B

    1. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

  4. Schöfl, C

    1. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;

  5. Schwaninger, M

    1. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;

  6. Schwartz, T W

    1. Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
      S A Hjorth, K Thirstrup, D K Grandy and T W Schwartz
      Molecular Pharmacology June 1995, 47 (6) 1089-1094;

  7. Sinha, B K

    1. Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;

  8. Snyder, S H

    1. Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.
      X J Li, R H Xu, W B Guggino and S H Snyder
      Molecular Pharmacology June 1995, 47 (6) 1133-1140;

  9. Spadari, S

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

  10. Standifer, K M

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

  11. Swillens, S

    1. Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis.
      S Swillens
      Molecular Pharmacology June 1995, 47 (6) 1197-1203;

T

  1. Tephly, T R

    1. Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
      B L Coffman, M D Green, C D King and T R Tephly
      Molecular Pharmacology June 1995, 47 (6) 1101-1105;

  2. Thirstrup, K

    1. Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
      S A Hjorth, K Thirstrup, D K Grandy and T W Schwartz
      Molecular Pharmacology June 1995, 47 (6) 1089-1094;

  3. Thompson, L F

    1. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;

  4. Tondelli, L

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

  5. Toth, P T

    1. Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;

  6. Tucker, J B

    1. Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

V

  1. Verghese, M W

    1. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;

  2. Verri, A

    1. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

  3. Vige, X

    1. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

W

  1. Warner, M

    1. Cytochromes P450 of the 2D subfamily in rat brain.
      A Wyss, J A Gustafsson and M Warner
      Molecular Pharmacology June 1995, 47 (6) 1148-1155;

  2. Wilcox, R A

    1. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;

  3. Wu, H L

    1. Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;

  4. Wyss, A

    1. Cytochromes P450 of the 2D subfamily in rat brain.
      A Wyss, J A Gustafsson and M Warner
      Molecular Pharmacology June 1995, 47 (6) 1148-1155;

X

  1. Xu, J

    1. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

  2. Xu, R H

    1. Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.
      X J Li, R H Xu, W B Guggino and S H Snyder
      Molecular Pharmacology June 1995, 47 (6) 1133-1140;

Y

  1. Yanishevski, Y

    1. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
      E Y Krynetski, N F Krynetskaia, Y Yanishevski and W E Evans
      Molecular Pharmacology June 1995, 47 (6) 1141-1147;
Back to top

In this issue